Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example EvidenceVariable: GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo

Active as of 2024-11-21

Generated Narrative: EvidenceVariable 179689

version: 4; Last updated: 2023-12-04 15:43:55+0000

Profile: GroupAssignment

url: EvidenceVariable GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo

identifier: FEvIR Object Identifier/179689, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.13

version: 2.0.0-ballot

name: GroupAssignment_high_dose_xanomeline_vs_low_dose_xanomeline_vs_placebo

title: GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo

status: Active

date: 2024-11-21 14:09:14+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

This example of a GroupAssignment Profile describes a 3-arm trial (so handling='polychotomous') and lists the 3 trial arms in category.name elements. Because the definition of this EvidenceVariable Resource is fully expressed in the handling and category elements, the defintion.concept element uses a CodeableConcept for 'Defined in handling and category elements'.

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence CommunicationGroupAssignment

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

author: Brian S. Alper:

RelatedArtifacts

-TypeCitation
*Cite As

GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179689. Revised 2023-12-01. Available at: https://fevir.net/resources/EvidenceVariable/179689. Computable resource at: https://fevir.net/resources/EvidenceVariable/179689.

handling: polychotomous variable

category

name: high dose xanomeline

category

name: low dose xanomeline

category

name: placebo